drugset / Trial / NCT02552238

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

NCT02552238

Phase 3 Completed 174 enrolled Bracco Diagnostics, Inc
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study was to assess the safety and efficacy of Lumason-enhanced dobutamine stress echo (DSE) in subjects having a suboptimal left ventricular endocardial border delineation (LV EBD) at rest and who were scheduled for coronary angiography.

Timeline

Start
2015-10-12
Primary completion
2017-06-22
Completion
2018-02-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Lumason Diagnostic / imaging agent 2 ml Intravenous